T. Kehoe

Bone quality: A perspective from the food and drug administration

T. Kehoe, 2006, Current osteoporosis reports.

Respiratory effects of live influenza virus vaccine: healthy older subjects and patients with chronic respiratory disease.

R. Zeck, N. Solliday, T. Kehoe, 1976, The American review of respiratory disease.

Regulatory aspects of the development of drugs for metabolic bone diseases - FDA and EMA perspective.

E. Blind, Heidi Janssen, T. Kehoe, 2018, British journal of clinical pharmacology.

Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia.

J. Timpone, A. Dobs, T. Brown, 2004, The Journal of clinical endocrinology and metabolism.

Regulatory Perspectives in Pharmacometric Models of Osteoporosis

L. Lesko, J. Florian, S. Schmidt, 2018, Journal of clinical pharmacology.

Bisphosphonates for osteoporosis--where do we go from here?

Marcea Whitaker, Jia Guo, Theresa Kehoe, 2012, The New England journal of medicine.